TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish.

Samuel J Klempner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.